Business Wire

Inspur Information and NEC Deutschland Launch an HPCaaS Solution Accelerating Automotive Design Simulation in Europe

31.5.2022 10:09:00 EEST | Business Wire | Press release

Share

Inspur Information, a leading IT infrastructure solutions provider, and NEC Deutschland, an HPC solutions provider for scientific and engineering applications, have joined forces to provide an HPC as a Service (HPCaaS) solution for computer-aided engineering (CAE) to auto manufactures in Europe. Inspur and NEC seek to bring infrastructure resilience and energy efficiency to high-performance computing (HPC) via on-demand usage, deep integration, and advanced cooling technologies.

In Automotive R&D, design verification is the most lengthy and expensive process in vehicle development, including real-life collision testing. However, an HPC cluster powering CAE applications can virtualize this process. Simulations can be performed faster, and without the expense of damaging real vehicles. The joint HPCaaS solution with Inspur-powered hardware and NEC system integration and implementation, allows for precise CAE simulations, such as vehicle crash simulations, computational fluid dynamics (CFD), structural mechanics, wind resistance, wind noise, thermal management, fatigue durability, welding simulation, stamping analysis, noise analysis, etc. This solution can provide more flexible and scalable computing resources and efficiency to meet the needs of customers' on-demand requirements.

The use of Inspur’s leading HPC servers for automotive CAE, greatly improve performance, lower energy consumption, and reduce data center space requirements by up to 50%. This results in virtualized simulations that are environmentally friendly, increased development speed, and a reduction in new vehicle R&D costs by up to 70%. This power is further harnessed via Inspur’s parameter tuning and application optimization for CAE simulations, along with NEC’s rich experience in system integration.

A German auto manufacturer with an annual production of over 450,000 vehicles is one of the largest recipients of this new HPC solution for CAE automotive manufacturing from Inspur and NEC. The company required powerful and green HPC clusters to support its manufacturing development over the next 3-4 years as part of an overall HPCaaS concept.

The Inspur-NEC HPC cluster significantly improved HPC performance for this auto manufacturer while still fulfilling the requirements for environmental sustainability, restricted power consumption, and reduced TCO. It utilizes Inspur’s NF5180M6 1U dual-socket rack server for maximum performance, high-density, and low power consumption.

The Inspur NF5180M6 servers are powered by 3rd Generation Intel® Xeon® Scalable processors, DDR4 3200MhHz memory, and Mellanox's latest HDR InfiniBand network, giving it the ultimate performance-to-size ratio in a petite 1U chassis. Trapezoidal radiators increase the surface area for improved heat dissipation and the BMC control strategy is optimized for peak efficency. This reduces fan power consumption, and enables support up to two 270W high-performance CPUs. Further power savings comes from an advanced platinum power supply that limits energy losses to less than 5%. Using the same power consumption levels, Inspur’s NF5180M6 performance in collision simulations improved by 30% compared to previous generation solutions.

This is a testament to Inspur’s ability to design infrastructure solutions that are both green and powerful, offering improved utilization of CAE software applications and collision simulation in the fields of engine development, cooling systems, vehicle flow field, and aerodynamic development design. With its green and efficient HPC server products, Inspur helped this automotive manufacturer run multiple HPC subsystems and more than 150 CAE applications that satisfy performance requirements, significantly reduce TCO, and promote environmental sustainability.

“Demand for vehicle personalization, autonomous driving, and electrification is growing,” said Liu Jun, Vice President of Inspur Information and General Manager of AI and HPC. “The automotive industry’s R&D investment in the field of high-performance computing continues to grow. The joint solution with NEC Deutschland will help automobile companies to improve competitiveness, innovation, and efficiency.”

Yuichi Kojima, Managing Director at NEC Deutschland said that “Computing power is fundamental to innovation speed and product quality. Based on Inspur’s high performance products and energy-saving technologies, and our capability to meet customers’ demands faster and easier, we can help Europe advance its digitalization efforts and be a showcase for sustainable development.”

Inspur Information is the world’s second largest server provider. Its servers and solutions have been widely used in various industries globally. According to Gartner, Inspur server shipments ranked second worldwide in 2021 with a 9.4% market share. It is a member of the European Technology Platform for High Performance Computing (ETP4HPC) and is committed to co-building an ecosystem boosting the development of HPC industry in the region.

About Inspur Information

Inspur Information is a leading provider of data center infrastructure, cloud computing, and AI solutions. It is the world’s 2nd largest server manufacturer. Through engineering and innovation, Inspur Information delivers cutting-edge computing hardware design and extensive product offerings to address important technology sectors such as open computing, cloud data center, and AI. Performance-optimized and purpose-built, our world-class solutions empower customers to tackle specific workloads and real-world challenges. To learn more, visit https://www.inspursystems.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Fiona Liu
PR Manager
Inspur Information
liuxuan01@inspur.com
Constanze Kreil
constanze.kreil@allisonpr.com
+49 (0)151 210 289 97

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye